Company intelligence
LinusBio
Precision Exposome Medicine
Biotechnology Research
North Brunswick, US
31 employees
Founded 2020
3 public signals
About LinusBio
Linus Biotechnology is a patient-centric, breakthrough science, precision exposome medicine company. Our program pipeline comprises precision exposome medicine biomarkers and target discovery across disease domains for which historically no molecular endpoints have been available in medical practice or for clinical trials, including CNS (autism spectrum disorder, amyotrophic lateral sclerosis), gastroenterology (inflammatory bowel disease), renal disease and oncology.
Verified activity
Signals from LinusBio
3 published signals
Presence & Recognition
LinusBio's Dr. Manish Arora will join the panel
Reported by LinusBio
Presence & Recognition
LinusBio will be attending the LSX Congress USA in Boston at Room 304 on Wednesday at 1:30 ET for a conversation on digital health and pharma-biotech partnerships.
Reported by Manish Arora
Research & Knowledge
LinusBio developed the Traced environmental exposure test, which splits a single hair lengthwise and reads layers to map 15 elements across about 30 days.
Reported by Manish Arora